Table 3 Exploratory outcomes
Parameters | Group Rop8 (n = 30) | Group Rop10 (n = 30) | P-value | |
|---|---|---|---|---|
Hypoxemia (n, %) | 0 | 0 | 1 | |
Bradycardia (n, %) | 1 (3.3) | 1 (3.3) | 1 | |
Hypotension (n, %) | 9 (30.0) | 8 (26.7) | 0.774 | |
Nausea and vomiting (n, %) | 2 (6.7) | 2 (6.7) | 1 | |
Visceral tract reaction 1–2–3 (n, %) | 25–5–0 | 28–2–0 | 0.228 | |
Shivering level 0–1–2–3 (n, %) | 24–3–3–0 | 24–2–4–0 | 0.842 | |
Muscle relaxation 1–2–3 (n, %) | 29–1–0 | 29–1–0 | 1 | |
Sedation level 0–1–2–3 (n, %) | 15–4–11–0 | 21–5–4–0 | 0.112 | |
Lidocaine (ml) | 6.67 ± 2.44 | 5.77 ± 1.88 | 0.291 | |
VAS of pain | ||||
At skin incision | 0 | 0 | 1 | |
At fetal delivery | 0.70 ± 1.09 | 0.37 ± 0.72 | 0.167 | |
At peritoneal closure | 0.20 ± 0.67 | 0.23 ± 0.73 | 0.854 | |
At skin closure | 0 | 0.07 ± 0.25 | 0.155 | |
Patient satisfaction 1–2–3–4–5 (n, %) | 0–0–0–7–23 | 0–0–0–3–27 | 0.166 | |
Umbilical vein PH | 7.35 ± 0.04 | 7.35 ± 0.03 | 0.751 | |
Apgar 1 min | 9 (9,9) | 9 (9,9) | 0.647 | |
Apgar 5 min | 10 (10,10) | 10 (10,10) | 1 | |